NICE is told to break its close links with drug industryBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7416.637 (Published 18 September 2003) Cite this as: BMJ 2003;327:637
- Zosia Kmietowicz
The National Institute for Clinical Excellence (NICE) has been advised by an independent review to break its close links with the drug industry and to make its processes more transparent.
Experts from the World Health Organization who carried out the review have advised NICE that, to avoid any possible bias, pharmaceutical physicians should not be members of committees that make judgments on particular drugs …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial